Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,463 recalls · Class I, newest first

Class I · High risk

LEOPARD Miracle Honey packaged in a wooden box

Marketed Without An Approved NDA/ANDA: product tainted with undeclared sildenafil, an FDA approved drug for the treatment of male erectile dysfunction. The presence of sildenafil in Leopard Miracle Honey renders it an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.

Terminated Chemical / undeclared USA LESS Inc. D-1135-2019
Class I · High risk

Golean DETOX capsules

Marketed Without an Approved NDA/ANDA: FDA analysis found product to contain undeclared sibutramine and phenolphthalein. Sibutramine is an appetite suppressant that was withdrawn from the US market due to safety concerns. Phenolphthalein was once an ingredient used in over-the-counter laxatives, but because of concerns of carcinogenicity is not currently approved for marketing in the US. The presence of sibutramine and phenolphthalein in this product renders it an unapproved drug for which the safety and efficacy has not been established and, therefore, subject to recall.

Terminated Nitrosamine impurity Golean Detox US D-1009-2019
Class I · High risk

Maeng Da Kratom

MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS: Analysis of samples were positive for Salmonella.

Terminated Microbial contamination Todd Holiday dba Sunstone Organics D-0989-2019
Class I · High risk

White Vein Kratom

MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS: Analysis of samples were positive for Salmonella.

Terminated Microbial contamination Todd Holiday dba Sunstone Organics D-0988-2019
Class I · High risk

White Vein Kratom

MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS: Analysis of samples were positive for Salmonella.

Terminated Microbial contamination Todd Holiday dba Sunstone Organics D-0987-2019
Class I · High risk

Maeng Da Kratom

MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS: Analysis of samples were positive for Salmonella.

Terminated Microbial contamination Todd Holiday dba Sunstone Organics D-0986-2019
Class I · High risk

Ceftriaxone for Injection USP

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-644-01 D-0358-2019
Class I · High risk

Ceftriaxone for Injection USP

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-633-01 D-0357-2019
Class I · High risk

Ceftriaxone for Injection USP

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-622-01 D-0356-2019
Class I · High risk

Ceftriaxone for Injection USP

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-611-01 D-0355-2019
Class I · High risk

Lubrisine eye drops

Lack of Sterility Assurance and Incorrect/Undeclared excipient: Product was found to contain undeclared colloidal silver

Terminated Sterility / contamination Results RNA, LLC D-0360-2019
Class I · High risk

Dyural-80 Injection Kit

Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recalled by the manufacturer due to the product insert incorrectly stating stoppers do not contain latex. The stoppers contain natural rubber latex

Terminated Labeling / mix-up Asclemed USA Inc. dba Enovachem NDC 76420-0755-01 D-0354-2019
Class I · High risk

Dyural-40 Injection Kit

Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recalled by the manufacturer due to the product insert incorrectly stating stoppers do not contain latex. The stoppers contain natural rubber latex

Terminated Labeling / mix-up Asclemed USA Inc. dba Enovachem NDC 76420-0750-01 D-0353-2019
Class I · High risk

Phenylephrine HCl

Labeling: Label Error on Declared Strength: Label incorrectly lists concentration as "10 mcg per mL" rather than the correct concentration of "100 mcg per mL".

Terminated Labeling / mix-up Advanced Pharma Inc. D-0347-2019
Class I · High risk

Sodium Chloride Injection

Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect statement on the product insert for product codes 918610 and 918620 indicating that the stoppers do not contain natural rubber latex. The tray label for these two product codes and the vial label for product code 918620 also incorrectly state that the stoppers do not contain latex. The above listed product codes and batches being recalled have stoppers containing natural rubber latex.

Terminated Labeling / mix-up Fresenius Kabi USA, LLC NDC 63323-186-20 D-0299-2019
Class I · High risk

Sodium Chloride Injection

Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect statement on the product insert for product codes 918610 and 918620 indicating that the stoppers do not contain natural rubber latex. The tray label for these two product codes and the vial label for product code 918620 also incorrectly state that the stoppers do not contain latex. The above listed product codes and batches being recalled have stoppers containing natural rubber latex.

Terminated Labeling / mix-up Fresenius Kabi USA, LLC NDC 63323-186-10 D-0298-2019
Class I · High risk

Levetiracetam in 0.54 % Sodium Chloride Injection 1

Labeling: Label Error on Declared Strength; the pre-printed text on the primary infusion bag and the NDC incorrectly identifies the product as Levetiracetam in 0.75% Sodium Chloride (1000 mg/100 mL) however, the external foil pouch correctly identifies the product as Levetiracetam in 0.54% Sodium Chloride Injection (1,500/100 mL).

Terminated Labeling / mix-up Dr. Reddy's Laboratories, Inc. NDC 43598-637-52 D-0485-2019

Recalls by year